236 related articles for article (PubMed ID: 9743331)
1. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo.
Sigal LJ; Reiser H; Rock KL
J Immunol; 1998 Sep; 161(6):2740-5. PubMed ID: 9743331
[TBL] [Abstract][Full Text] [Related]
2. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.
Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB
J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
4. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
5. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
[TBL] [Abstract][Full Text] [Related]
6. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
7. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
Schweitzer AN; Sharpe AH
J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
[TBL] [Abstract][Full Text] [Related]
8. Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma.
van Rijt LS; Vos N; Willart M; Kleinjan A; Coyle AJ; Hoogsteden HC; Lambrecht BN
J Allergy Clin Immunol; 2004 Jul; 114(1):166-73. PubMed ID: 15241361
[TBL] [Abstract][Full Text] [Related]
9. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
10. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
[TBL] [Abstract][Full Text] [Related]
11. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H
Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141
[TBL] [Abstract][Full Text] [Related]
12. B7.2 (CD86) but not B7.1 (CD80) costimulation is required for the induction of low dose oral tolerance.
Liu L; Kuchroo VK; Weiner HL
J Immunol; 1999 Aug; 163(4):2284-90. PubMed ID: 10438973
[TBL] [Abstract][Full Text] [Related]
13. B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro.
Gajewski TF
J Immunol; 1996 Jan; 156(2):465-72. PubMed ID: 8543795
[TBL] [Abstract][Full Text] [Related]
14. B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination.
Santra S; Barouch DH; Sharpe AH; Letvin NL
Eur J Immunol; 2000 Sep; 30(9):2650-9. PubMed ID: 11009099
[TBL] [Abstract][Full Text] [Related]
15. Intercellular adhesion molecule-1 is necessary but not sufficient to activate CD4+ T cells. Discovery of a novel costimulator on kidney tubule cells.
Hagerty DT
J Immunol; 1996 May; 156(10):3652-9. PubMed ID: 8621899
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.
Kim TS; Lee BC; Kim E; Cho D; Cohen EP
Vaccine; 2008 Nov; 26(47):5928-34. PubMed ID: 18793691
[TBL] [Abstract][Full Text] [Related]
17. Enhanced generation of cytotoxic T lymphocytes using recombinant vaccinia virus expressing human tumor-associated antigens and B7 costimulatory molecules.
Zajac P; Schütz A; Oertli D; Noppen C; Schaefer C; Heberer M; Spagnoli GC; Marti WR
Cancer Res; 1998 Oct; 58(20):4567-71. PubMed ID: 9788602
[TBL] [Abstract][Full Text] [Related]
18. Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages.
Flores Villanueva PO; Reiser H; Stadecker MJ
J Immunol; 1994 Dec; 153(11):5190-9. PubMed ID: 7525726
[TBL] [Abstract][Full Text] [Related]
19. Importance of B7-1-expressing host antigen-presenting cells for the eradication of B7-2 transfected P815 tumor cells.
La Motte RN; Sharpe AH; Bluestone JA; Mokyr MB
J Immunol; 1998 Dec; 161(12):6552-8. PubMed ID: 9862681
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
